1. Advancing the Treatment of IBD With Biologics

3. Background

4. Progression of IBD

5. Limitations of Conventional IBD Therapies

6. Anti-TNF Therapies for IBD

7. Evolution of Treatment Goals for IBD

8. Anti-TNF Therapies for IBD (cont)

9. Safety and Tolerability of Anti-TNF Therapies for IBD

10. New Biologic Therapies for IBD

11. Efficacy of New Biologic Therapies for IBD

12. How to Compare Biologic Agents

13. Safety of New Biological Therapies for IBD

14. Immunogenicity of Anti-TNF Therapy

15. Immunogenicity of Biologic Agents

16. Selecting a Biologic for the Patient

17. Selecting a Biologic for the Patient (cont)

18. Selecting a Biologic for the Patient (cont)

19. Emerging Therapies for IBD: Integrins

20. Emerging Therapies for IBD: Small Molecules

21. Issues for Future Treatment of IBD

22. Treating to Target

23. Therapeutic Drug Monitoring

24. Stopping Biologic Therapy

25. Summary and Outlook

26. Abbreviations

27. Abbreviations (cont)